Compare Occidental Petroleum Corporation (OXY) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Occidental Petroleum (OXY) trades at $60.65, up 1.02% today, with a bullish technical signal from moving averages and a consensus analyst price target of $68.67. The company has beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.40 surpassing expectations of $1.83. Financials show strong profitability with a 30.32% net income margin and robust cash flow from operations of $10.53 billion in 2025, though revenue has declined from $36.6 billion in 2022 to $21.6 billion in 2025.

OXY presents a positive outlook with debt reduction progress and projected net income margin rebound to 30.31% in 2026. Investment opportunities include potential upside to the price target and sustainable cash flow growth. Risks include oil price volatility, geopolitical tensions affecting energy markets, and execution challenges in maintaining profitability amid fluctuating revenues.

Regeneron Pharmaceuticals (REGN) trades at $810.31, down 2.1% today, with strong fundamentals including 84.9% gross margins and consistent earnings beats. The stock shows bullish technical signals with support at $805 and resistance at $838, while analyst consensus remains strongly positive with 69% buy ratings. Recent news highlights multiple class action lawsuits related to clinical trial disclosures, creating near-term sentiment headwinds despite solid financial performance.

Outlook remains cautiously optimistic given strong profitability and analyst support, though legal risks and clinical trial uncertainties present challenges. The stock trades above consensus price target of $756.82, suggesting limited near-term upside potential despite robust fundamentals and institutional confidence.